查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386400

动物用药品市场报告：2030 年趋势、预测与竞争分析

Veterinary Medication Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

动物用药品趋势及预测

预计到 2030 年，全球动物用药品市场将达到 622 亿美元，2024 年至 2030 年复合年增长率为 7.1%。市场的主要驱动力是宠物主人数量的增加、全球畜牧业人口的增加以及动物慢性疾病风险的增加。全球动物用药品市场前景广阔，兽药局和零售兽药市场蕴藏商机。

动物用药品市场洞察

Lucintel 预测，肠外药物由于其易于获得且起效快，将继续成为最大的细分市场。

在这个市场中，预计兽医院药局将在预测期内出现高速成长。

预计北美地区在预测期内将出现最高的成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球动物用药品市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球动物用药品市场趋势（2018-2023）与预测（2024-2030）
  • 全球动物用药品市场（按产品）
    • 药物
    • 疫苗
    • 药用饲料添加剂
  • 按给药途径分類的全球动物用药品市场
    • 口服
    • 胃肠外的
    • 外用
  • 按配销通路分類的全球动物用药品市场
    • 动物医院药房
    • 零售兽药局
  • 按动物类型分類的全球动物用药品市场
    • 伴同性动物
    • 家畜

第四章 2018-2030年区域市场趋势及预测分析

  • 全球动物用药品市场区域分布
  • 北美动物用药品市场
  • 欧洲动物用药品市场
  • 亚太动物用药品市场
  • 其他区域动物用药品市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球动物用药品市场成长机会（按产品）
    • 按给药途径给药的全球动物用药品市场成长机会
    • 按配销通路的全球动物用药品市场成长机会
    • 按动物类型分類的全球动物用药品市场成长机会
    • 按地区分類的全球动物用药品市场成长机会
  • 全球动物用药品市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球动物用药品市场的产能
    • 全球动物用药品市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis
简介目录

Veterinary Medication Trends and Forecast

The future of the global veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets. The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals.

A more than 150-page report is developed to help in your business decisions.

Veterinary Medication by Segment

The study includes a forecast for the global veterinary medication by product, route of administration, distribution channel, animal type, and region.

Veterinary Medication Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Vaccines
  • Medicated Feed Additives

Veterinary Medication Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Route
  • Parenteral Route
  • Topical Route

Veterinary Medication Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Hospitals Pharmacies
  • Retail Veterinary Pharmacies

Veterinary Medication Market by Animal Type [Shipment Analysis by Value from 2018 to 2030]:

  • Companion Animals
  • Livestock Animals

Veterinary Medication Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Veterinary Medication Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies veterinary medication companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary medication companies profiled in this report include-

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis

Veterinary Medication Market Insights

Lucintel forecasts that parenteral will remain the largest segment due to its easy availability and quick onset of action.

Within this market, veterinary hospital pharmacy is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Veterinary Medication Market

Market Size Estimates: Veterinary medication market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Veterinary medication market size by various segments, such as by product, route of administration, distribution channel, animal type, and region in terms of ($B).

Regional Analysis: Veterinary medication market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, distribution channels, animal types, and regions for the veterinary medication market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary medication market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the veterinary medication market size?

Answer: The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030.

Q.2 What is the growth forecast for veterinary medication market?

Answer: The global veterinary medication market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the veterinary medication market?

Answer: The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals.

Q4. What are the major segments for veterinary medication market?

Answer: The future of the veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets.

Q5. Who are the key veterinary medication market companies?

Answer: Some of the key veterinary medication companies are as follows:

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis

Q6. Which veterinary medication market segment will be the largest in future?

Answer: Lucintel forecasts that parenteral will remain the largest segment due to its easy availability and quick onset of action.

Q7. In veterinary medication market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the veterinary medication market by product (drugs, vaccines, and medicated feed additives), route of administration (oral route, parenteral route, and topical route), distribution channel (veterinary hospitals pharmacies and retail veterinary pharmacies), animal type (companion animals and livestock animals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Veterinary Medication Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Veterinary Medication Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Veterinary Medication Market by Product
    • 3.3.1: Drugs
    • 3.3.2: Vaccines
    • 3.3.3: Medicated Feed Additives
  • 3.4: Global Veterinary Medication Market by Route of Administration
    • 3.4.1: Oral Route
    • 3.4.2: Parenteral Route
    • 3.4.3: Topical Route
  • 3.5: Global Veterinary Medication Market by Distribution Channel
    • 3.5.1: Veterinary Hospitals Pharmacies
    • 3.5.2: Retail Veterinary Pharmacies
  • 3.6: Global Veterinary Medication Market by Animal Type
    • 3.6.1: Companion Animals
    • 3.6.2: Livestock Animals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Veterinary Medication Market by Region
  • 4.2: North American Veterinary Medication Market
    • 4.2.2: North American Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.3: European Veterinary Medication Market
    • 4.3.1: European Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.3.2: European Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.4: APAC Veterinary Medication Market
    • 4.4.1: APAC Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.4.2: APAC Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.5: ROW Veterinary Medication Market
    • 4.5.1: ROW Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.5.2: ROW Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Veterinary Medication Market by Product
    • 6.1.2: Growth Opportunities for the Global Veterinary Medication Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Veterinary Medication Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Veterinary Medication Market by Animal Type
    • 6.1.5: Growth Opportunities for the Global Veterinary Medication Market by Region
  • 6.2: Emerging Trends in the Global Veterinary Medication Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Veterinary Medication Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Veterinary Medication Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Virbac
  • 7.2: Merck
  • 7.3: Archer Daniels Midland
  • 7.4: Dechra Pharmaceuticals
  • 7.5: Ceva Sante Animale
  • 7.6: Boehringer Ingelheim
  • 7.7: Soparfin
  • 7.8: Elanco Animal Health
  • 7.9: Evonik Industries AG
  • 7.10: Zoetis